TY - JOUR
KW - Pioglitazone
KW - buprenorphine
KW - opioid withdrawal
KW - Cytokines
KW - opioid dependence
KW - Clinical Trial
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Inpatient
KW - Outpatient
KW - Adulthood (18 yrs & older)
KW - Young Adulthood (18-29 yrs)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - Aged (65 yrs & older)
KW - Drugs
KW - Drug Abuse
KW - Adjunctive Treatment
KW - opioid use disorder
KW - Drug Therapy
KW - Opiates
KW - article
KW - US
KW - 3340:Clinical Psychopharmacology
KW - Analgesics, Opioid
KW - Double-Blind Method
KW - Humans
KW - Middle Aged
KW - Substance Withdrawal Syndrome
KW - Narcotic Antagonists
KW - opioid-related disorders
KW - Adult
KW - Opiate Substitution Treatment
AU - Jennifer R. Schroeder
AU - Karran A. Phillips
AU - David H. Epstein
AU - Michelle L. Jobes
AU - Melody A. Furnari
AU - Ashley P. Kennedy
AU - Markus Heilig
AU - Kenzie L. Preston
A1 - 
AD - Johns Hopkins Bayview Medical Center, Baltimore, MD, US ; National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, US kpreston@intra.nida.nih.gov; Center for Social and Affective Neuroscience, IKE, Linkoping Univ, Linkoping, Sweden ; Preston, Kenzie L.,251 Bayview Blvd., BRC Building, Suite 200,Baltimore,US,21224,National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health,kpreston@intra.nida.nih.gov
BT - Psychopharmacology
C5 - Measures; Opioids & Substance Use
CP - 10
DO - 10.1007/s00213-018-4986-5
IS - 10
JF - Psychopharmacology
LA - English
M1 - Journal Article
PB - Springer
PY - 2018
SN - 0033-3158, 0033-3158
SP - 2957
EP - 2966
EP - 
T1 - Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder
T2 - Psychopharmacology
TI - Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder
U1 - Measures; Opioids & Substance Use
U3 - 10.1007/s00213-018-4986-5
VL - 235
VO - 0033-3158, 0033-3158
Y1 - 2018
Y2 - 10
ER -